Analytical Data
-
基因名
STK38L
- Application
-
别名
STK38L；KIAA0965；NDR2；Serine/threonine-Protein kinase 38-like
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9Y2H1
-
表达区间
212-464aa
-
氨基酸序列
RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCIDSENRIGNSGVEEIKGHPFFEGVDWEHIRERPAAIPIEIKSIDDTSNFDDFPESDILQPVPNTTEPDYKSKDWVFLNYTYKRFEGLTQRGSIPTYMKAGKL
-
分子量
33.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
STK38L, also known as Serine/Threonine Kinase 38-like, is a member of the STK family of protein kinases that has garnered attention in recent years for its potential roles in various cellular processes and pathologies. Research has indicated that STK38L is involved in regulating cellular signaling pathways, particularly those linked to cell growth, proliferation, and survival. This kinase is thought to have implications in cancer biology, where dysregulation of signaling pathways can lead to unrestrained cellular growth and metastasis. Additionally, STK38L may play a role in neurodevelopmental disorders, given its expression patterns in the brain. Investigating STK38L as a recombinant protein allows researchers to elucidate its functional properties, interaction with other cellular molecules, and its overall contribution to disease mechanisms. The development of STK38L recombinant protein provides a valuable tool for drug discovery and therapeutic development, as targeting specific kinases has become a prominent strategy in cancer treatment and other diseases. Moreover, understanding the structure and function of STK38L at a molecular level could open up new avenues for therapeutic interventions. Overall, the study of STK38L and its recombinant protein holds promising potential to advance our knowledge in both basic and applied biomedical research.
